121 related articles for article (PubMed ID: 20524836)
41. Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features.
Takahashi M; Yang XJ; Lavery TT; Furge KA; Williams BO; Tretiakova M; Montag A; Vogelzang NJ; Re GG; Garvin AJ; Söderhäll S; Kagawa S; Hazel-Martin D; Nordenskjold A; Teh BT
Cancer Res; 2002 Nov; 62(22):6598-605. PubMed ID: 12438255
[TBL] [Abstract][Full Text] [Related]
42. Immunohistochemical detection of p53 in Wilms' tumors correlates with unfavorable outcome.
Lahoti C; Thorner P; Malkin D; Yeger H
Am J Pathol; 1996 May; 148(5):1577-89. PubMed ID: 8623926
[TBL] [Abstract][Full Text] [Related]
43. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
[TBL] [Abstract][Full Text] [Related]
44. Neural cell adhesion molecule (NCAM) isoform expression is associated with neuroblastoma differentiation status.
Winter C; Pawel B; Seiser E; Zhao H; Raabe E; Wang Q; Judkins AR; Attiyeh E; Maris JM
Pediatr Blood Cancer; 2008 Jul; 51(1):10-6. PubMed ID: 18213713
[TBL] [Abstract][Full Text] [Related]
45. Expression of the RNA component of telomerase in Wilms tumor and nephrogenic rest recapitulates renal embryogenesis.
Yashima K; Maitra A; Timmons CF; Rogers BB; Pinar H; Shay JW; Gazdar AF
Hum Pathol; 1998 May; 29(5):536-42. PubMed ID: 9596280
[TBL] [Abstract][Full Text] [Related]
46. p53 Immunohistochemistry expression in Wilms tumor: a prognostic tool in the detection of tumor aggressiveness.
Franken J; Lerut E; Van Poppel H; Bogaert G
J Urol; 2013 Feb; 189(2):664-70. PubMed ID: 23036984
[TBL] [Abstract][Full Text] [Related]
47. Etiology of Wilms' tumor.
Sharpe CR; Franco EL
Epidemiol Rev; 1995; 17(2):415-32. PubMed ID: 8654519
[TBL] [Abstract][Full Text] [Related]
48. Imaging Characteristics of Nephrogenic Rests Versus Small Wilms Tumors: A Report From the Children's Oncology Group Study AREN03B2.
Sandberg JK; Chi YY; Smith EA; Servaes S; Hoffer FA; Mullen EA; Perlman EJ; Tornwall B; Ehrlich PF; Geller JI; Grundy PE; Fernandez CV; Dome JS; Khanna G
AJR Am J Roentgenol; 2020 May; 214(5):987-994. PubMed ID: 32160052
[No Abstract] [Full Text] [Related]
49. Polysialylated neural cell adhesion molecule as a marker for differential diagnosis in pediatric tumors.
Glüer S; Schelp C; Gerardy-Schahn R; von Schweinitz D
J Pediatr Surg; 1998 Oct; 33(10):1516-20. PubMed ID: 9802804
[TBL] [Abstract][Full Text] [Related]
50. Comparative immunohistochemical analysis of developing kidneys, nephroblastomas and related tumors: considerations on their histogenesis.
Satoh F; Tsutsumi Y; Yokoyama S; Osamura RY
Pathol Int; 2000 Jun; 50(6):458-71. PubMed ID: 10886722
[TBL] [Abstract][Full Text] [Related]
51. Universal expression of cell adhesion molecule NCAM in neuroblastoma in contrast to L1: implications for different roles in tumor biology of neuroblastoma?
Wachowiak R; Rawnaq T; Metzger R; Quaas A; Fiegel H; Kähler N; Rolle U; Izbicki JR; Kaifi J; Till H
Pediatr Surg Int; 2008 Dec; 24(12):1361-4. PubMed ID: 18972120
[TBL] [Abstract][Full Text] [Related]
52. Aberrant activation, nuclear localization, and phosphorylation of Yes-associated protein-1 in the embryonic kidney and Wilms tumor.
Murphy AJ; Pierce J; de Caestecker C; Libes J; Neblett D; de Caestecker M; Perantoni AO; Tanigawa S; Anderson JR; Dome JS; Das A; Carroll TJ; Lovvorn HN
Pediatr Blood Cancer; 2014 Feb; 61(2):198-205. PubMed ID: 24115727
[TBL] [Abstract][Full Text] [Related]
53. Hyaluronic acid-stimulating activity in the pathophysiology of Wilms' tumors.
Longaker MT; Adzick NS; Sadigh D; Hendin B; Stair SE; Duncan BW; Harrison MR; Spendlove R; Stern R
J Natl Cancer Inst; 1990 Jan; 82(2):135-9. PubMed ID: 2152946
[TBL] [Abstract][Full Text] [Related]
54. Embryonal Origin of Metanephric Adenoma and its Differential Diagnosis.
Sarlos DP; Banyai D; Peterfi L; Szanto A; Kovacs G
Anticancer Res; 2018 Dec; 38(12):6663-6667. PubMed ID: 30504374
[TBL] [Abstract][Full Text] [Related]
55. Ureteric Bud-derivatives in Wilms Tumor and Nephrogenic Rest.
Sarkany B; Kovacs G; Banyai D
In Vivo; 2021; 35(4):2159-2162. PubMed ID: 34182492
[TBL] [Abstract][Full Text] [Related]
56. Peptide spectra in Wilms tumor that associate with adverse outcomes.
Murphy AJ; Pierce J; Seeley EH; Sullivan LM; Ruchelli ED; Nance ML; Caprioli RM; Lovvorn HN
J Surg Res; 2015 Jun; 196(2):332-8. PubMed ID: 25868780
[TBL] [Abstract][Full Text] [Related]
57. Immunohistochemical profiling of Wilms tumor: a tissue microarray study.
Vasei M; Moch H; Mousavi A; Kajbafzadeh AM; Sauter G
Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):128-34. PubMed ID: 18227731
[TBL] [Abstract][Full Text] [Related]
58. Wilms Tumor NCAM-Expressing Cancer Stem Cells as Potential Therapeutic Target for Polymeric Nanomedicine.
Markovsky E; Vax E; Ben-Shushan D; Eldar-Boock A; Shukrun R; Yeini E; Barshack I; Caspi R; Harari-Steinberg O; Pode-Shakked N; Dekel B; Satchi-Fainaro R
Mol Cancer Ther; 2017 Nov; 16(11):2462-2472. PubMed ID: 28729402
[TBL] [Abstract][Full Text] [Related]
59. [The developmental expression of embryonic-neural cell adhesive molecule in human olfactory mucosa].
Ren X; Ding Y; Shi L; Chen Y
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 May; 18(5):259-60. PubMed ID: 15311500
[TBL] [Abstract][Full Text] [Related]
60. The varied spectrum of nephroblastomatosis, nephrogenic rests, and Wilms tumors: Review of current definitions and challenges of the field.
Fialkowski E; Sudour-Bonnange H; Vujanic GM; Shamberger RC; Chowdhury T; Aldrink JH; Davick J; Sandberg J; Furtwaengler R; Mullen E
Pediatr Blood Cancer; 2023 May; 70 Suppl 2():e30162. PubMed ID: 36545945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
